Metropolis Healthcare Limited is among the leading diagnostic companies in India. The company has a great geographical presence across nations including India, the Middle East, Africa, and South Asia.
Financial Results:
In the third quarter of FY23, the company suffered a drop of 12.77 percent YoY in net profits from INR 41.04 crore in Q3FY22 to INR 35.80 crore. The company also reported a drop of 2.60 percent YoY in revenue from operations which stood at INR 285.46 crore in the quarter ended December 2022 as compared to INR 295.03 crore in the quarter ended December 2021.
Metropolis Healthcare Limited reported net expenses of INR 244.10 crore in the third quarter of FY23. This is in comparison to INR 239.57 crore which was recorded in the year-ago quarter. As compared to the EPS of INR 8.02 in the year-ago period, the company reported an EPS of INR 6.99 in Q3FY23.